Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Experimental Neurobiology is Scopus-indexed (Q2, CiteScore 3.9), WoS SCIE. Published by Korean Society for Neurodegenerative Disease.
Checked against the index lists dated .
ISSN 1226-2560Verify ISSN ↗2093-8144Verify ISSN ↗
Publisher: Korean Society for Neurodegenerative Disease
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 195 / 403 | 51st | Q2 |
| Cellular and Molecular Neuroscience | 73 / 102 | 28th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q2, CiteScore 3.9.
Experimental Neurobiology is Q2 in Neurology (clinical) (rank 195 of 403) and Q3 in Cellular and Molecular Neuroscience (rank 73 of 102), by CiteScore 2025.
Experimental Neurobiology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.9, which places it in quartile Q2 at the 51st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.944, quartile Q2, with an H-index of 37.
Experimental Neurobiology is published by Korean Society for Neurodegenerative Disease. Its print ISSN is 1226-2560 and its online ISSN is 2093-8144.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Experimental Neurobiology has an h-index of 61 and a 2-year mean of 1.89 citations per paper (OpenAlex). Its Scopus CiteScore is 3.9, quartile Q2. On 2-year citations it ranks #164 of 403 Scopus journals in Neurology (clinical).
Experimental Neurobiology published 26 papers in 2025; its busiest recent year was 2019 with 61. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2023–2026), authors are most often from South Korea (82%), China (7.5%) and United States (5.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.